ut-logo website  
Register and login to access premium content
Log in
Express registration and login!
If you have a Facebook or LinkedIN account, use one of the buttons on the left to either login or create a new account.

Log in

 

Prostate Cancer


banner prostate-awareness

Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer - Abstract

Prostate cancer is the most commonly diagnosed cancer disease in men in the Unites States and its management remains a challenge in everyday oncology practice.

Read more...

Best practices recommendations in the application of immunohistochemistry in urologic pathology: Report from the International Society of Urological Pathology Consensus Conference - Abstract

Members of the International Society of Urological Pathology (ISUP) participated in a half-day consensus conference to discuss guidelines and recommendations regarding best practice approaches to use of immunohistochemistry (IHC) in differential diagnostic situations in urologic pathology, including bladder, prostate, testis and, kidney lesions.

Read more...

Copy number alteration burden predicts prostate cancer relapse - Abstract

Primary prostate cancer is the most common malignancy in men but has highly variable outcomes, highlighting the need for biomarkers to determine which patients can be managed conservatively.

Read more...

Luteolin, ellagic acid and punicic acid are natural products that inhibit prostate cancer metastasis - Abstract

Prostate cancer (PCa) is the second cause of cancer deaths in men in the USA.

Read more...

Pathologic fracture in patients with metastatic prostate cancer - Abstract

PURPOSE OF REVIEW: This review will describe the management of patients with prostate cancer and bone metastases with a particular emphasis on recent advances in this area.

Read more...

Significance of image guidance to clinical outcomes for localized prostate cancer - Abstract

Purpose: To compare toxicity profiles and biochemical tumor control outcomes between patients treated with image-guided intensity-modulated radiotherapy (IG-IMRT) and non-IGRT intensity-modulated radiotherapy (IMRT) for clinically localized prostate cancer.

Read more...

Ethnicity is an independent determinant of age-specific PSA level: Findings from a multiethnic Asian setting - Abstract

OBJECTIVES: To study the baseline PSA profile and determine the factors influencing the PSA levels within a multiethnic Asian setting.

Read more...

Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: Longitudinal analysis - Abstract

PURPOSE: Rectal swabs can identify men with fluoroquinolone (FQ)-resistant bacteria and reduce rates of infection after transrectal ultrasound guided prostate biopsy (TRUSB) by targeted antimicrobial prophylaxis.

Read more...

Prostate cancer in a man with a BRCA2 mutation and a personal history of bilateral breast cancer - Abstract

BACKGROUND: Men with a BRCA2 mutation face substantial lifetime risks for the development of both breast and prostate cancer.

Read more...

Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer - Abstract

BACKGROUND: In a previous study we demonstrated that, based on 11C/18 F-choline positron emission tomography-computerized-tomography as a diagnostic tool, salvage lymph node dissection (LND) plus adjuvant radiotherapy (ART) is feasible for treatment of pelvic/retroperitoneal nodal recurrence of prostate cancer (PCa).

Read more...

Page 1 of 1014